Resistance to Targeted Therapies in Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics (21), Band 21)

Targeted Therapies in Lymphomas
Wo zu kaufen (2) Eigenschaften
Gesponsert
Resistance to Targeted Therapies in Lymphomas: Enthält: 1 Buch, 1 E-Book (Resistance to Targeted Anti-Cancer Therapeutics, 21, Band 21)
Medimops DE
98.99 EUR
Preis aktualisiert am: 30-04-2026 12:08:40
Siehe Produktangebot
Gesponsert
Resistance to Targeted Therapies in Lymphomas
SpringerLink DE
106.99 EUR
Preis aktualisiert am: 30-04-2026 14:05:33
Siehe Produktangebot

Allgemein

Marke
Springer

Eigenschaften

Ähnliche Produkte

Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)
Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)
Produkt anzeigen
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Produkt anzeigen
Resistance to Molecular Therapies for Hepatocellular Carcinoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 13)
Resistance to Molecular Therapies for Hepatocellular Carcinoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 13)
Produkt anzeigen
TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)
TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)
Produkt anzeigen
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)
Produkt anzeigen
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics)
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics)
Produkt anzeigen
Menü